Today, Bitget, in collaboration with media outlet Rhythm, held an online live broadcast themed "Dialogue with Bitget Executives: A Comprehensive Breakdown of the SpaceX Ticket, from Capital Privilege to Universal Sharing," providing a systematic interpretation of the product mechanisms of IPO Prime and preSPAX.
Ken, the product head of Bitget IPO Prime, stated that IPO Prime is not the traditional "new coin listing," but rather utilizes digital tokens issued by the regulated issuer Republic to transform the high-threshold, low-liquidity non-standard assets of the primary market into priceable, tradable, and exit-able digital products.
Ken pointed out that Pre-IPO opportunities have long been scarce, not only because the targets are of high quality but also due to the inherent high thresholds, strong circles, and low liquidity issues in the primary market. The launch of IPO Prime by Bitget aims to provide users with the opportunity to access potential economic benefits before the listing of unicorn companies through clearer product design and trading mechanisms within a compliant framework.
The first phase of the preSPAX launched is an important attempt in this direction, focusing on providing users with a more flexible and tradable participation path.
He further stated that from crypto trading to UEX, and now extending to the primary market, Bitget has been continuously pushing the boundaries of trading. In the future, the platform hopes to do more than just list more assets; it aims to further bridge the previously fragmented opportunity structures between different markets, allowing users to access earlier, higher quality, and more diverse global asset opportunities within the same system.
This content is provided for general informational purposes only and doesn't constitute financial, investment, legal, or tax advice. Any events, rewards, online promotions, or related information mentioned herein should not be considered a recommendation, solicitation, or invitation to purchase, sell, trade, or otherwise deal in any crypto assets. Crypto assets are highly volatile and may result in loss. The availability of WEEX services, products, and related events may vary by region. You are responsible for ensuring that your participation is in accordance with applicable local laws and regulations.












Moderna shares more than doubled on 19 August 2026 after Merck and Moderna said the Phase 3 INTerpath-001 trial of intismeran autogene plus KEYTRUDA met its recurrence-free survival endpoint in resected melanoma. This page explains what the result is, why the stock reacted this hard, what is still unknown, which dates come next (presentation and earnings, both unconfirmed), and what a trader can actually do on WEEX — which does not list Moderna; the nearest instrument is the XBI-USDT biotech ETF perpetual. No price targets, no forecasts.















Long-end U.S. Treasury yields surged to multi-year highs, pressuring technology, semiconductor, storage, and optical communication stocks and driving a clear cooling in market risk appetite. At the same time, Anthropic’s revenue came in below some bullish expectations, prompting investors to reassess the AI growth narrative; Unitree Robotics officially listed on the STAR Market, extending momentum in robotics and embodied AI; while SpaceX and other commercial space names showed relative resilience. Investors are now focused on tonight’s Federal Reserve minutes for clearer signals on the policy path and broader market sentiment.


